Arkolith/Insider Trading/BNTC/Form 4

Suvretta Capital Management, LLC

Director, 10% OwnerBenitec Biopharma Inc. (BNTC) · full profile →Form 4 · filed Nov 10, 2025
Net Buying
Open-Market Buys
$20.0M
Open-Market Sells
$0
Net Open-Market Flow
$20.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 7, 2025Buy(P)751K$13.50$10.1M1.8M
Nov 7, 2025Buy(P)730K$13.50$9.9M9.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899140-25-001256) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML